Form D — Quanta Therapeutics, Inc.
0001891891-26-000002 · filed 2026-06-24
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $89,098,282
- Total sold
- $76,192,272
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Quanta Therapeutics, Inc.
- CIK
- 1891891
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- TWO TOWER PLACE, FLOOR 17
SOUTH SAN FRANCISCO, CA 94080 - Phone
- (970) 742-4190
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Perry Nisen · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Maria Fardis · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Rajul Jain · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Ying Huang · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Derek Metzger · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Maha Katabi · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Cameron Pitt · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
View original on SEC EDGAR.